ClearCure Biosciences, Inc
ClearCure Biosciences is a clinical-stage biopharmaceutical company focused on developing non-toxic, first-in-class and best-in-class therapies for cancer, infectious diseases, sepsis, neurological diseases, and cardiovascular conditions. The company emphasizes drugging challenging targets, leveraging proprietary small molecules, nanotechnology, cell therapies, AI and omics-driven approaches, and digital health solutions to address serious unmet medical needs.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Novel small molecule therapeutics (pipeline)
Pipeline includes a range of small molecule drugs and new molecular entities for transforming previously untreatable diseases into curable or preventable conditions. The first product to market is a non-toxic intravenous therapy for sepsis.
Novel small molecule therapeutics (pipeline)
Pipeline includes a range of small molecule drugs and new molecular entities for transforming previously untreatable diseases into curable or preventable conditions. The first product to market is a non-toxic intravenous therapy for sepsis.
Expertise Areas
- Oncology therapeutics
- Infectious disease treatment
- Sepsis and septic shock intervention
- Neuroscience drug development
Key Technologies
- Small molecule therapeutics
- Targeted protein modulation
- Cell-based therapy
- Nanotechnology-based delivery